Back to MNPR

ADAR1 Capital Management, LLC → MNPR

ADAR1 Capital Management, LLC MNPR Position History

Monopar Therapeutics Inc. • Healthcare

Quarters held
5
Latest value
$14.3M
Q3 2026
Peak value
$20.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$15.3M
Q4 2025$15.3M
Q1 2026$14.5M
Q2 2026$20.1M
Q3 2026$14.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$14.3M179.0K——
Q2 2026$20.1M217.6K——
Q1 2026$14.5M264.3K——
Q4 2025$15.3M233.9K——
Q4 2025$15.3M233.9K——

Other funds holding MNPR

Other ADAR1 Capital Management, LLC positions

AAVXF

ABIVAX SA

$240.5M
AAVXF

ABIVAX SA

$203.1M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$155.2M
SPY

STATE STR SPDR S&P 500 ETF T

$135.5M
PB

PROTAGONIST THERAPEUTICS INC

$134M
PB

PROTAGONIST THERAPEUTICS INC

$117.8M